ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
ICU MEDICAL INC/DE
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$161.24−1.75 (-1.07%)
Close on Oct 19, 2026
- Market cap
- $4.04B
- P/E (TTM)
- 134.4
- Dividend yield
- –
ICU MEDICAL INC/DE revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infusion Consumables [Member] | $289.28M | $278.28M | $284.68M | $285.09M | $273.13M | $266.23M | $268.14M | $264.88M | $261.82M | $244.04M | $254.02M | $242.01M | 52.4% | +5.9% |
| Infusion Systems [Member] | $189.00M | $179.60M | $176.30M | $173.91M | $167.70M | $166.30M | $171.67M | $159.77M | $163.64M | $157.34M | $165.21M | $148.98M | 34.3% | +12.7% |
| Vital Care | $73.41M | $72.35M | $79.72M | $77.99M | $108.04M | $172.18M | $190.00M | $164.49M | $171.00M | $165.28M | $168.63M | $162.32M | 13.3% | -32.1% |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $349.90M | $315.50M | $325.31M | $307.13M | $335.43M | $388.25M | $413.29M | $369.52M | $383.14M | $366.16M | $376.98M | $355.98M | 63.4% | +4.3% |
| EMEA [Member] | $95.07M | $104.68M | $101.85M | $115.09M | $99.06M | $95.69M | $98.12M | $101.71M | $95.31M | $98.39M | $96.58M | $88.01M | 17.2% | -4.0% |
| Asia Pacific | $55.63M | $58.30M | – | $57.48M | $58.40M | $59.41M | – | $60.29M | $61.22M | $51.85M | – | $59.06M | 10.1% | -4.7% |
| Other foreign countries [Member] | $51.08M | $51.75M | $55.94M | $57.29M | $55.97M | $61.36M | $58.94M | $57.62M | $56.78M | $50.26M | $50.32M | $50.25M | 9.3% | -8.7% |
From the segment and revenue-disaggregation notes of Icu Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.